These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34940536)

  • 1. Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis.
    Izumida T; Imamura T; Nakamura M; Kinugawa K
    J Cardiovasc Dev Dis; 2021 Dec; 8(12):. PubMed ID: 34940536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotropic Assessment in Patients with Constrictive Pericarditis.
    Imamura T; Narang N; Besser S; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):811-815. PubMed ID: 34234074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Heart Rate in Patients with Left Ventricular Assist Devices.
    Imamura T; Kinugawa K; Narang N; Nishida H; Pinney S; Jeevanandam V; Ota T
    Int Heart J; 2022; 63(1):56-61. PubMed ID: 35095077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implication of optimal heart rate in patients with systolic dysfunction following TAVR.
    Imamura T; Tanaka S; Ushijima R; Sobajima M; Fukuda N; Ueno H; Besser S; Kinugawa K
    J Card Surg; 2021 Apr; 36(4):1328-1333. PubMed ID: 33538004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Estimate the Optimal Heart Rate in Patients with Heart Failure with Preserved Ejection Fraction.
    Izumida T; Imamura T; Fukui T; Koi T; Ueno Y; Hori M; Nakagaito M; Tanaka S; Kataoka N; Ushijima R; Nakamura M; Sobajima M; Fukuda N; Ueno H; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):816-820. PubMed ID: 34276013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to consider target heart rate in patients with systolic heart failure.
    Izumida T; Imamura T; Nakamura M; Fukuda N; Kinugawa K
    ESC Heart Fail; 2020 Oct; 7(5):3231-3234. PubMed ID: 32592292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of heart rate optimization in patients with heart failure.
    Hori M; Imamura T; Kinugawa K
    J Cardiol Cases; 2021 Apr; 23(4):163-165. PubMed ID: 33841593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
    Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
    ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.
    Nguyen LS; Squara P; Amour J; Carbognani D; Bouabdallah K; Thierry S; Apert-Verneuil C; Moyne A; Cholley B
    Crit Care; 2018 Aug; 22(1):193. PubMed ID: 30115103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of atrial fibrillation on left ventricle function in the elderly].
    Wysokiński A; Zapolski T
    Pol Arch Med Wewn; 2005 Mar; 113(3):223-30. PubMed ID: 16128279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
    Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
    Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortening of atrioventricular delay at increased atrial paced heart rates improves diastolic filling and functional class in patients with biventricular pacing.
    Rafie R; Qamruddin S; Ozhand A; Taha N; Naqvi TZ
    Cardiovasc Ultrasound; 2012 Jan; 10():2. PubMed ID: 22269022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
    Nakahashi T; Arita T; Yamaji K; Inoue K; Yokota T; Hoshii Y; Fukunaga M; Nomura A; Watanabe H; Miura S; Isotani A; Soga Y; Ando K; Iwabuchi M; Yokoi H; Nosaka H; Yamagishi M; Nobuyoshi M
    Int J Cardiol; 2014 Oct; 176(3):753-9. PubMed ID: 25131905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction.
    Imamura T; Onoda H; Uchida K; Kinugawa K
    Int Heart J; 2021 Nov; 62(6):1305-1309. PubMed ID: 34744149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
    Guzman M; Gomez R; Romero SP; Aranda R; Andrey JL; Pedrosa MJ; Egido J; Gomez F
    Int J Clin Pract; 2018 Nov; 72(11):e13217. PubMed ID: 30248211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study.
    Villacorta AS; Villacorta H; Caldas JA; Precht BC; Porto PB; Rodrigues LU; Neves M; Xavier AR; Kanaan S; Mesquita CT; da Nóbrega ACL
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):139-145. PubMed ID: 30198318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 24-hour blood pressure and heart rate on the prognosis of patients with reduced and midrange LVEF.
    Mareev VY; Kapanadze LG; Kheimets GI; Mareev YV
    Kardiologiia; 2021 Jul; 61(7):4-13. PubMed ID: 34397336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.